Amoxicillin Plant in Tennessee Reopens to Add to the U.S. Stockpile
USAntibiotics will reopen its amoxicillin plant in Bristol, Tenn., that shut down last year as part of the company’s bankruptcy and it expects to produce 300 million capsules and 2 billion tablets of the drug a year.
The company, which was purchased by Jackson Healthcare in April, plans to produce a five-year supply of the antibiotic for the U.S. government stockpile. At full capacity, the facility will be able to meet 100 percent of the U.S. demand for the antibiotic.
Amoxicillin, which belongs to the penicillin family, accounts for 30 percent of all antibiotics prescribed annually in the U.S.